Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.74 | N/A |
| PEG Ratio (TTM) | 12.75 | N/A |
| P/S Ratio (TTM) | 2.76 | N/A |
| P/B Ratio (TTM) | 1.25 | N/A |
| P/FCF Ratio (TTM) | 15.10 | N/A |
| Price to 5YR AVG Earnings Ratio | 13.58 | N/A |
| Price to 5YR AVG FCF Ratio | 11.09 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.95% | N/A |
| ROE (TTM) | 8.83% | N/A |
| Net Profit Margin (TTM) | 18.75% | N/A |
| ROIC 5YR AVG | 15.32% | N/A |
Growth (55%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.06% | 7.25% | 2.24% |
| Revenue | 13.94% | -1.39% | 10.96% |
| Net Income | 2.31% | 5.31% | 0.87% |
| Cash Flow | 27.88% | 18.04% | 3.32% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.95 | N/A |
| Quick Ratio (TTM) | 0.95 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | 1.71 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.28 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | -1.40% | N/A |